image
Evelo Biosciences, Inc. EVLO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.00045
0 %
$ 8.54 K
Market Cap
0.0
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-108 M OPERATING INCOME
6.01%
Growth Rates
1Year 6.01%
3Years -7.89%
5Years -31.55%
7Years 0.00%
10Years 0.00%
-115 M NET INCOME
6.26%
Growth Rates
1Year 6.26%
3Years -10.25%
5Years -32.50%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Evelo Biosciences, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 108 M
Operating Income -108 M
Other Expenses 6.06 M
Net Income -115 M

Income Statement

Millions
Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
REVENUE
Revenue 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 108.5 115.4 91.9 86.4 58.1 27.5 13.0
Selling, General and Administrative Expenses 29.9 31.8 22.3 23.2 18.2 7.6 3.9
Research and Development Expenses 78.6 83.6 69.6 63.1 39.9 20.0 9.1
Operating Income (108.5) (115.4) (91.9) (86.4) (58.1) (27.5) (13.0)
PRE-TAX INCOME
Interest Income Expense 4.7 3.6 2.11 K 1.0 1.6 0 0
Total Other Income (5.1) (6.4) (1.4) 0.9 1.2 (0.5) (0.3)
Pre-Tax Income (113.6) (121.7) (93.3) (85.5) (56.9) (28.0) (13.3)
NET INCOME
Tax Provision 0.9 0.4 0.4 0.2 (3.1) 0.2 0.3
Net Income (114.5) (122.2) (93.7) (85.7) (53.9) (28.0) (13.3)
EPS 26.3 46.2 47.5 53.5 49.2 150 94.5